Barriers to the optimal use of anticoagulants after orthopaedic surgery

Archives of Orthopaedic and Trauma Surgery

Volumn 129, Issue 11, 2009, Pages 1441-1445

  Borris, L C ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Deep vein thrombosis; Factor Xa inhibitors; Orthopaedic surgery; Pulmonary embolism; Risk factor stratification; Venous thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ENOXAPARIN; FONDAPARINUX; LOW MOLECULAR WEIGHT HEPARIN; RIVAROXABAN; WARFARIN;

ARTICLE; DECISION SUPPORT SYSTEM; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG USE; EUROPE; HIGH RISK PATIENT; HUMAN; ORTHOPEDIC SURGERY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; POSTOPERATIVE THROMBOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SELF INJECTION; THROMBOSIS PREVENTION; TREATMENT DURATION; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; GUIDELINE ADHERENCE; HUMANS; ORTHOPEDIC PROCEDURES; PRACTICE GUIDELINES AS TOPIC; PULMONARY EMBOLISM; RISK FACTORS; THROMBOEMBOLISM;

EID: 70349908390     PISSN: 09368051     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00402-008-0765-9     Document Type: Article

References (46)

1. Anderson FA Jr, White K (2002) Prolonged prophylaxis in orthopedic surgery: Insights from the United States. Semin Thromb Hemost 28(Suppl 3):43-46
2. Arnold DM, Kahn SR, Shrier I (2001) Missed opportunities for prevention of venous thromboembolism: An evaluation of the use of thromboprophylaxis guidelines. Chest 120:1964-1971
3. Aujesky D, Guignard E, Pannatier A et al (2002) Pharmacological thromboembolic prophylaxis in a medical ward: Room for improvement. J Gen Intern Med 17:788-791
4. Bergqvist D (1993) Long-term prophylaxis following orthopedic surgery. Haemostasis 23(Suppl 1):27-31
5. Bergqvist D, Jonsson B (1999) Cost-effectiveness of prolonged administration of a low molecular weight heparin for the prevention of deep venous thrombosis following total hip replacement. Value Health 2:288-294
6. Blackburn J, Schumock G, Bauman J (2005) Barriers to appropriate anticoagulation with warfarin in orthopedic surgery. J Thromb Haemost 3(Suppl 1):PO430
7. Borris LC, Breindahl M, Ryge C et al (2007) Prothrombin fragment 1+2 in urine as an indicator of sustained coagulation activation after total hip arthroplasty. Thromb Res 121:369-376
8. Brenkel IJ, Cook RE (2003) Thromboprophylaxis in patients undergoing total hip replacement. Hosp Med 64:281-287
9. Brenkel IJ, Hyers TM (2004) Thromboprophylaxis in patients undergoing hip replacement: A survey of British orthopaedic surgeons. J Bone Joint Surg Br 87(Suppl III):277
10. Caprini JA, Hyers TM (2006) Compliance with antithrombotic guidelines. Manag Care 15:49-60, 66
11. Cohen AT, Alikhan R, Arcelus JI et al (2005) Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. Thromb Haemost 94:750-759
12. Cohen AT, Tapson VF, Bergmann JF et al (2008) Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 371:387-394
13. Cohn SL, Adekile A, Mahabir V (2006) Improved use of thromboprophylaxis for deep vein thrombosis following an educational intervention. J Hosp Med 1:331-338
14. Dahl OE (1999) Mechanisms of hypercoagulability. Thromb Haemost 82:902-906
15. Dahl OE (2000) Continuing out-of-hospital prophylaxis following major orthopaedic surgery: What now? Haemostasis 30(Suppl 2):101-105
16. Dahl OE (2004) Orthopaedic surgery as a model for drug development in thrombosis. Drugs 64(Suppl 1):17-25
17. Eriksson BI, Quinlan DJ (2006) Oral anticoagulants in development: Focus on thromboprophylaxis in patients undergoing orthopaedic surgery. Drugs 66:1411-1429
18. Eriksson BI, Borris LC, Friedman RJ et al (2008) Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med 358:2765-2775
19. Geerts WH, Pineo GF, Heit JA et al (2004) Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126:338S-400S
20. Gross M, Anderson DR, Nagpal S et al (1999) Venous thromboembolism prophylaxis after total hip or knee arthroplasty: A survey of Canadian orthopedic surgeons. Can J Surg 42:457-461
21. Haas S (2003) Medical indications and considerations for future clinical decision making. Thromb Res 109:S31
22. Haas S, Schellong S (2007) New anticoagulants: From bench to bedside. Hamostaseologie 27:41-47
23. Kakkar VV, Cohen AT, Edmonson RA et al (1993) Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. The Thromboprophylaxis Collaborative Group. Lancet 341:259-265
24. Kakkar AK, Levine M, Pinedo HM et al (2003) Venous thrombosis in cancer patients: Insights from the FRONTLINE survey. Oncologist 8:381-388
25. Kakkar AK, Davidson BL, Haas SK (2004) Compliance with recommended prophylaxis for venous thromboembolism: Improving the use and rate of uptake of clinical practice guidelines. J Thromb Haemost 2:221-227
26. Kakkar AK, Brenner B, Dahl OE et al (2008) Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: A double-blind, randomised controlled trial. Lancet 372:31-39
27. Koch A, Ziegler S, Breitschwerdt H et al (2001) Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis: meta-analysis based on original patient data. Thromb Res 102:295-309
28. Lassen MR, Ageno W, Borris LC et al (2008) Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med 358:2776-2886
29. Learhinan ER, Alderman CP (2003) Venous thromboembolism prophylaxis in a South Australian teaching hospital. Ann Pharmacother 37:1398-1402
30. Levine MN, Raskob G, Beyth RJ et al (2004) Hemorrhagic complications of anticoagulant treatment: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126:287S-310S
31. Lieberman JR, Hsu WK (2005) Prevention of venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am 87:2097-2112
32. Mismetti P, Laporte S, Darmon JY et al (2001) Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg 88:913-930
33. Rosendaal FR (1999) Venous thrombosis: A multicausal disease. Lancet 353:1167-1173
34. Salvati EA, Pellegrini VD Jr, Sharrock NE et al (2000) Recent advances in venous thromboembolic prophylaxis during and after total hip replacement. J Bone Joint Surg Am 82:252-270
35. Scaglione L, Piobbici M, Pagano E et al (2005) Implementing guidelines for venous thromboembolism prophylaxis in a large Italian teaching hospital: Lights and shadows. Haematologica 90:678-684
36. Schunemann HJ, Cook D, Grimshaw J et al (2004) Antithrombotic and thrombolytic therapy: FrTm evidence to application: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126:688S-696S
37. Select Committee on Health of the United Kingsom (2005) Second Report. Hansard
38. Tapson VF, Goldhaber SZ (2003) Failure to provide prophylaxis for deep vein thrombosis: Results from the DVT-Free registry. Blood 102:322a
39. Tooher R, Middleton P, Pham C et al (2005) A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals. Ann Surg 241:397-415
40. Turpie AG (2007) Oral, direct Factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases. Arterioscler Thromb Vasc Biol 27:1238-1247
41. Vallano A, Arnau De Bolos JM et al (2004) Use of venous thromboprophylaxis and adherence to guideline recommendations: A cross-sectional study. Thromb J 2:3
42. Venous thromboembolism: Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients undergoing surgery (2007) National Institute of Health and Clinical Excellence Guideline 46
43. Walker N, Rodgers A, Gray H (2002) Changing patterns of pharmacological thromboprophylaxis use by orthopaedic surgeons in New Zealand. ANZ J Surg 72:335-338
44. Wan S, Ting J, Olsen A et al (2003) Thromboprophylaxis practice patterns in hip fracture surgery patients: Experience in Perth, Western Australia. ANZ J Surg 73:826-829
45. Warwick D, Friedman RJ, Agnelli G et al (2007) Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: Findings from the Global Orthopaedic Registry. J Bone Joint Surg Br 89:799-807
46. Zaw HM, Osborne IC, Pettit PN et al (2002) Risk factors for venous thromboembolism in orthopedic surgery. Isr Med Assoc J 4:1040-1042